Form 4: Edwards Lifesciences Executive Larry L. Wood Reports Stock Disposal

Sentiment:

SEC Form 4 Filing


Larry L. Wood, Global President TAVR & Surg at Edwards Lifesciences, reported disposing of 333 shares of common stock to cover tax obligations.

Summary

  • On February 16, 2025, Larry L. Wood, Global President TAVR & Surg at Edwards Lifesciences, disposed of 333 shares of common stock.
  • The transaction was executed at a price of $76.19 per share.
  • Following the transaction, Wood directly owns 198,192.739 shares of Edwards Lifesciences common stock.
  • Wood also indirectly owns 148.1703 shares through a 401(k) plan.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing a stock disposal, which is neutral in sentiment. It doesn't indicate any significant positive or negative developments for the company.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders. This allows investors to track the buying and selling activity of executives and directors, which can provide insights into their perspectives on the company's performance and future prospects.

Key Dates

DateDescription
02/16/2025Date of stock disposal transaction
02/18/2025Date of signature on the Form 4 filing

Keywords

Form 4, Beneficial Ownership, Edwards Lifesciences, EW, Larry L. Wood, TAVR, Stock Disposal, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.